Earnings History Data for Dynavax Technologies Corporation (DVAX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Dynavax Technologies Corporation

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		DVAX	Dynavax Technologies Corporation	1,570	0.12	0.10	0.10	Dynavax GAAP EPS of $0.12 beats by $0.01, revenue of $80.63M misses by $3.54M [11/7/2024 4:07 PM]	13.01	0.99 (8.19%)	12.33	0.31 (2.58%)	9.74 - 15.01	4,202,773	2,440,000	1,518
Dynavax announces $200M share repurchase program [11/7/2024 4:08 PM] Dynavax GAAP EPS of $0.12 beats by $0.01, revenue of $80.63M misses by $3.54M [11/7/2024 4:07 PM] Dynavax rises 11% on Q3 bottom line beat, 2024 positive net income expectation [11/8/2024 12:04 PM] Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates [2024-11-07 04:02PM] Dynavax Announces $200 Million Share Repurchase Program [2024-11-07 04:01PM] Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript [Nov-07-24 11:15PM] Dynavax Technologies (DVAX) Q3 Earnings Surpass Estimates [Nov-07-24 05:25PM] Dynavax Technologies: Q3 Earnings Snapshot [Nov-07-24 04:18PM]
06-08-2024	AH		DVAX	Dynavax Technologies Corporation	1,430	0.08	0.06	0.03	Dynavax GAAP EPS of $0.08 beats by $0.02, revenue of $73.8M misses by $2.24M [8/6/2024 4:05 PM]	10.75	0.70 (6.97%)	9.91	-0.14 (-1.39%)	9.74 - 15.15	11,235,012	1,670,000	123,892
Dynavax GAAP EPS of $0.08 beats by $0.02, revenue of $73.8M misses by $2.24M [8/6/2024 4:05 PM]
08-05-2024	AH		DVAX	Dynavax Technologies Corporation	1,520	-0.07	-0.04	-0.19	Dynavax GAAP EPS of -$0.07 misses by $0.04, revenue of $50.79M misses by $4.19M [5/8/2024 4:02 PM]	10.98	-0.67 (-5.71%)	11.25	-0.40 (-3.43%)	10.48 - 15.15	3,985,714	1,870,000	7,025
Dynavax drops 6% as quarterly results miss on both lines [5/8/2024 5:45 PM] Dynavax GAAP EPS of -$0.07 misses by $0.04, revenue of $50.79M misses by $4.19M [5/8/2024 4:02 PM]
22-02-2024	AH		DVAX	Dynavax Technologies Corporation	1,600	N/A	-0.01	0.45	Dynavax GAAP EPS of $0.00 beats by $0.01, revenue of $55.6M beats by $2.87M [2/22/2024 4:02 PM]	12.74	0.30 (2.41%)	12.65	0.21 (1.69%)	9.42 - 15.15	2,606,047	1,770,000	1,056
Dynavax GAAP EPS of $0.00 beats by $0.01, revenue of $55.6M beats by $2.87M [2/22/2024 4:02 PM]
02-11-2023	AH		DVAX	Dynavax Technologies Corporation	1,830	0.10	-0.01	0.43	Dynavax beats Q3 top and bottom line estimates; updates FY23 outlook [11/2/2023 4:20 PM]	14.24	0.17 (1.24%)	14.90	0.83 (5.90%)	9.42 - 15.15	2,430,511	1,560,000	1,380
Dynavax beats Q3 top and bottom line estimates; updates FY23 outlook [11/2/2023 4:20 PM]
03-08-2023	AH		DVAX	Dynavax Technologies Corporation	1,770	0.03	-0.09	0.86	Dynavax GAAP EPS of $0.03 beats by $0.12, revenue of $60.25M beats by $11.87M [8/3/2023 4:36 PM]	14.48	1.09 (8.18%)	13.98	0.59 (4.41%)	9.42 - 17.48	5,960,831	1,580,000	13,096
Dynavax GAAP EPS of $0.03 beats by $0.12, revenue of $60.25M beats by $11.87M [8/3/2023 4:36 PM]
02-05-2023	AH	4:05 PM ET (May 2)	DVAX	Dynavax Technologies Corporation	1,340	-0.19	-0.12	0.22	Dynavax GAAP EPS of -$0.19 misses by $0.06, revenue of $46.92M beats by $8.33M [5/2/2023 4:12 PM]	10.98	0.67 (6.55%)	10.31	0.0 (0.00%)	7.26 - 17.48	1,658,938	1,010,000	11,682
Dynavax GAAP EPS of -$0.19 misses by $0.06, revenue of $46.92M beats by $8.33M [5/2/2023 4:12 PM] Dynavax misses on bottom line, but reaffirms 2023 guidance [5/2/2023 5:11 PM]
23-02-2023	AH	4:05 PM ET (Feb 23)	DVAX	Dynavax Technologies Corporation	1,420	0.45	0.46	0.55	Dynavax GAAP EPS of $0.45 in-line, revenue of $184.49M beats by $6.11M [2/23/2023 4:11 PM]	10.36	-0.41 (-3.85%)	10.80	0.03 (0.28%)	7.26 - 17.48	4,912,725	1,280,000	1,461
Dynavax GAAP EPS of $0.45 in-line, revenue of $184.49M beats by $6.11M [2/23/2023 4:11 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	DVAX	Dynavax Technologies Corporation	1,470	0.43	0.33	0.06	Dynavax GAAP EPS of $0.43 beats by $0.10, revenue of $167.74M beats by $8.33M [11/3/2022 4:16 PM]	12.55	1.39 (12.40%)	11.26	0.09 (0.81%)	7.26 - 21.39	2,522,972	1,920,000	2,669
Dynavax GAAP EPS of $0.43 beats by $0.10, revenue of $167.74M beats by $8.33M [11/3/2022 4:16 PM] Dynavax Technologies (DVAX) Q3 2022 Earnings Call Transcript [Nov-03-22 10:00PM] Dynavax Technologies (DVAX) Beats Q3 Earnings and Revenue Estimates [Nov-03-22 07:25PM]
04-08-2022	AH	4:00 PM ET (Aug 4)	DVAX	Dynavax Technologies Corporation	1,870	0.86	0.22	0.02	Dynavax GAAP EPS of $0.87 beats by $0.65, revenue of $256.46M beats by $105.47M [8/4/2022 4:06 PM]	16.65	2.31 (16.11%)	16.65	0.0 (0.00%)	7.26 - 21.39	5,964,784	1,440,000	6,350
Dynavax GAAP EPS of $0.87 beats by $0.65, revenue of $256.46M beats by $105.47M [8/4/2022 4:06 PM] Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats [8/4/2022 5:42 PM] Dynavax Reports Second Quarter 2022 Financial Results [Aug-04-22 04:02PM] Is Axonics (AXNX) Stock Outpacing Its Medical Peers This Year? [Aug-04-22 09:40AM] Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates [Aug-04-22 06:35PM]
05-05-2022	AH	4:00 PM ET (May 5)	DVAX	Dynavax Technologies Corporation	1,170	0.22	0.24	0.01	Dynavax GAAP EPS of $0.26 beats by $0.02, revenue of $114M misses by $40.29M [5/5/2022 4:06 PM]	8.96	0.21 (2.34%)	8.76	0.0 (0.00%)	7.09 - 21.39	2,754,785	1,690,000	1,479
Dynavax GAAP EPS of $0.26 beats by $0.02, revenue of $114M misses by $40.29M [5/5/2022 4:06 PM] Vaccine Makers Slump as Moderna, Pfizer Leave Full-Year Guidance Intact [May-04-22 02:25PM] Clovers Bivalent COVID-19 Vaccine Candidate Demonstrates Broad Neutralization Against Omicron and Other Variants of Concern [May-05-22 07:00AM] Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action [May-05-22 12:08PM] Dynavax Reports First Quarter 2022 Financial Results [May-05-22 04:02PM] Dynavax Technologies (DVAX) Misses Q1 Earnings and Revenue Estimates [May-05-22 06:05PM] Dynavax Technologies (DVAX) Q1 2022 Earnings Call Transcript [May-06-22 09:01AM]
28-02-2022	AH	4:00 PM ET (Feb 28)	DVAX	Dynavax Technologies Corporation	1,490	0.55	0.69	-0.14	Dynavax GAAP EPS of $0.55 misses by $0.09, revenue of $195.07M misses by $13.8M [2/28/2022 4:10 PM]	12.20	-0.06 (-0.49%)	12.15	-0.11 (-0.90%)	7.09 - 21.39	1,182,553	1,580,000	5,761
Dynavax GAAP EPS of $0.55 misses by $0.09, revenue of $195.07M misses by $13.8M [2/28/2022 4:10 PM] Dynavax Technologies Stock Sees Relative Strength Rating Rise To 85 [Feb-25-22 11:15AM] Dynavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Financial Guidance [Feb-28-22 04:02PM] Dynavax Technologies (DVAX) Lags Q4 Earnings and Revenue Estimates [Feb-28-22 06:05PM] Dynavax Technologies (DVAX) Q4 2021 Earnings Call Transcript [Feb-28-22 08:30PM] Endo (ENDP) Surpasses Q4 Earnings and Revenue Estimates [Mar-01-22 11:19AM] FATE's Loss Wider Than Expected in Q4, Pipeline in Focus [Mar-01-22 11:59AM] Why Dynavax Stock Dipped on Tuesday [Mar-01-22 07:08PM]
04-11-2021	AH	4:00 PM ET (Nov 4)	DVAX	Dynavax Technologies Corporation	2,360	0.06	0.05	-0.15	Dynavax EPS misses by $0.29, beats on revenue [11/4/2021 4:06 PM]	16.16	-4.60 (-22.16%)	18.20	-2.56 (-12.33%)	3.79 - 21.39	9,971,753	2,770,000	183,414
Dynavax EPS misses by $0.29, beats on revenue [11/4/2021 4:06 PM] Dynavax shares rise after Q3 topline beat [11/4/2021 4:36 PM] Dynavax Reports Third Quarter 2021 Financial Results [Nov-04-21 04:02PM] Dynavax Technologies (DVAX) Q3 Earnings and Revenues Surpass Estimates [Nov-04-21 06:35PM] Dynavax Technologies (DVAX) Q3 2021 Earnings Call Transcript [Nov-05-21 12:01PM] Why Dynavax Stock Is Falling Today [Nov-05-21 12:16PM]
04-08-2021	AH	4:00 PM ET (Aug 4)	DVAX	Dynavax Technologies Corporation	1,110	0.02	-0.04	-0.27	Dynavax EPS beats by $0.06, beats on revenue [8/4/2021 4:06 PM]	10.26	0.38 (3.85%)	9.98	0.10 (1.01%)	3.58 - 11.84	4,053,923	1,310,000	48,984
Dynavax EPS beats by $0.06, beats on revenue [8/4/2021 4:06 PM] Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Aug-03-21 04:10PM] Dynavax Announces Second Quarter 2021 Financial Results [Aug-04-21 04:02PM] Dynavax Technologies (DVAX) Q2 Earnings and Revenues Top Estimates [Aug-04-21 06:05PM]
06-05-2021	AH	4:00 PM ET (May 6)	DVAX	Dynavax Technologies Corporation	1,060	0.01	-0.02	-0.35	Dynavax EPS beats by $0.03, beats on revenue [5/6/2021 4:05 PM]	9.83	0.95 (10.70%)	9.05	0.17 (1.91%)	3.55 - 12.44	3,096,964	2,050,000	20,314
Dynavax EPS beats by $0.03, beats on revenue [5/6/2021 4:05 PM] Dynavax rallies on Q1 strong revenue led by CpG 1018 product revenue [5/7/2021 11:53 AM] Dynavax Technologies Corp. to Host Earnings Call [May-06-21 02:45PM] Dynavax Announces First Quarter 2021 Financial Results [May-06-21 04:02PM] Dynavax Technologies (DVAX) Beats Q1 Earnings and Revenue Estimates [May-06-21 06:50PM] How Dynavax Demolished Expectations With Its Q1 Results [May-07-21 06:02AM]
25-02-2021	AH	4:00 PM ET (Feb 25)	DVAX	Dynavax Technologies Corporation	1,000.00	-0.14	-0.24	-0.34	Dynavax EPS beats by $0.10, beats on revenue [2/25/2021 4:09 PM]	8.74	0.57 (7.05%)	9.12	0.96 (11.76%)	1.80 - 12.44	9,297,825	4,234,185	44,297
Dynavax EPS beats by $0.10, beats on revenue [2/25/2021 4:09 PM] Dynavax Technologies posts Q4 topline beat, shares rise [2/25/2021 4:38 PM] Dynavax surges on prospects for COVID–19 vaccine adjuvant [2/26/2021 1:51 PM] Dynavax's Q4 Results Show It's Not Just About Heplisav-B Anymore [Feb-26-21 06:00AM] Dynavax Technologies Corp. to Host Earnings Call [Feb-25-21 02:30PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	DVAX	Dynavax Technologies Corporation	438.05	-0.15	-0.20	-0.49	Dynavax EPS beats by $0.05, beats on revenue [11/5/2020 4:04 PM]	4.16	0.03 (0.73%)	4.37	0.24 (5.81%)	1.80 - 12.44	3,635,213	2,536,619	120,646

06-08-2020	AH	4:10 PM ET (Aug 6)	DVAX	Dynavax Technologies Corporation	974.81	-0.27	-0.24	-0.66	Dynavax EPS misses by $0.29, misses on revenue [8/6/2020 4:04 PM]	7.72	-1.10 (-12.53%)	8.18	-0.64 (-7.26%)	1.80 - 12.44	6,246,122	6,039,580	48,113